Merck & Co. (MRK)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of Merck & Co. (MRK)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
Key Insights
Critical company metrics and information
Share Price
$101.72Market Cap
$257.33 BillionTotal Outstanding Shares
2.53 Billion SharesTotal Employees
72,000Dividend
$0.81 Per Share QuarterlyIPO Date
April 20, 1949SIC Description
Pharmaceutical PreparationsHomepage
https://www.merck.com
Historical Stock Splits
Execution Date | Split Amount |
---|---|
No Historical Stock Splits |
Cash Flow Statement
July 1, 2024 to September 30, 2024
Metric | Value |
---|---|
Net Cash Flow, Continuing | $3.02 Billion |
Net Cash Flow From Financing Activities, Continuing | $-2.42 Billion |
Net Cash Flow | $3.31 Billion |
Net Cash Flow From Investing Activities | $-3.85 Billion |
Net Cash Flow From Operating Activities | $9.29 Billion |
Net Cash Flow From Investing Activities, Continuing | $-3.85 Billion |
Exchange Gains/Losses | $294.00 Million |
Net Cash Flow From Financing Activities | $-2.42 Billion |
Net Cash Flow From Operating Activities, Continuing | $9.29 Billion |
Income Statement
July 1, 2024 to September 30, 2024
Metric | Value |
---|---|
Operating Income/Loss | $4.09 Billion |
Diluted Average Shares | $2.54 Billion |
Income/Loss From Continuing Operations After Tax | $3.16 Billion |
Income Tax Expense/Benefit | $929.00 Million |
Revenues | $16.66 Billion |
Gross Profit | $12.58 Billion |
Net Income/Loss Attributable To Parent | $3.16 Billion |
Net Income/Loss Attributable To Noncontrolling Interest | $4.00 Million |
Benefits Costs and Expenses | $12.57 Billion |
Preferred Stock Dividends And Other Adjustments | $0.00 |
Costs And Expenses | $12.57 Billion |
Selling, General, and Administrative Expenses | $2.73 Billion |
Research and Development | $5.86 Billion |
Income Tax Expense/Benefit, Deferred | $-401.00 Million |
Income/Loss From Continuing Operations Before Tax | $4.09 Billion |
Basic Average Shares | $2.53 Billion |
Operating Expenses | $8.49 Billion |
Diluted Earnings Per Share | $1.24 |
Cost Of Revenue | $4.08 Billion |
Other Operating Expenses | $-107.00 Million |
Basic Earnings Per Share | $1.25 |
Net Income/Loss | $3.16 Billion |
Net Income/Loss Available To Common Stockholders, Basic | $3.16 Billion |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
Balance Sheet
July 1, 2024 to September 30, 2024
Metric | Value |
---|---|
Equity Attributable To Noncontrolling Interest | $58.00 Million |
Current Assets | $40.36 Billion |
Accounts Payable | $3.59 Billion |
Other Current Assets | $34.12 Billion |
Current Liabilities | $29.59 Billion |
Other Current Liabilities | $26.00 Billion |
Assets | $117.53 Billion |
Equity | $44.56 Billion |
Intangible Assets | $17.01 Billion |
Noncurrent Liabilities | $43.39 Billion |
Other Non-current Assets | $36.72 Billion |
Equity Attributable To Parent | $44.50 Billion |
Inventory | $6.24 Billion |
Liabilities | $72.97 Billion |
Fixed Assets | $23.45 Billion |
Liabilities And Equity | $117.53 Billion |
Noncurrent Assets | $77.17 Billion |
Historical Dividends
Current dividend: $0.81 Per Share Quarterly
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
Nov 19, 2024 | Jan 8, 2025 | Dec 16, 2024 | $0.81 | Quarterly |
Jul 23, 2024 | Oct 7, 2024 | Sep 16, 2024 | $0.77 | Quarterly |
May 28, 2024 | Jul 8, 2024 | Jun 17, 2024 | $0.77 | Quarterly |
Jan 23, 2024 | Apr 5, 2024 | Mar 15, 2024 | $0.77 | Quarterly |
Nov 28, 2023 | Jan 8, 2024 | Dec 15, 2023 | $0.77 | Quarterly |
Jul 25, 2023 | Oct 6, 2023 | Sep 15, 2023 | $0.73 | Quarterly |
May 23, 2023 | Jul 10, 2023 | Jun 15, 2023 | $0.73 | Quarterly |
Jan 24, 2023 | Apr 10, 2023 | Mar 15, 2023 | $0.73 | Quarterly |
Nov 29, 2022 | Jan 9, 2023 | Dec 15, 2022 | $0.73 | Quarterly |
Jul 26, 2022 | Oct 7, 2022 | Sep 15, 2022 | $0.69 | Quarterly |
May 24, 2022 | Jul 8, 2022 | Jun 15, 2022 | $0.69 | Quarterly |
Jan 25, 2022 | Apr 7, 2022 | Mar 15, 2022 | $0.69 | Quarterly |
Nov 30, 2021 | Jan 7, 2022 | Dec 15, 2021 | $0.69 | Quarterly |
Jul 27, 2021 | Oct 7, 2021 | Sep 15, 2021 | $0.65 | Quarterly |
May 25, 2021 | Jul 7, 2021 | Jun 15, 2021 | $0.65 | Quarterly |
Jan 26, 2021 | Apr 7, 2021 | Mar 15, 2021 | $0.65 | Quarterly |
Nov 17, 2020 | Jan 8, 2021 | Dec 15, 2020 | $0.65 | Quarterly |
Jul 28, 2020 | Oct 7, 2020 | Sep 15, 2020 | $0.61 | Quarterly |
May 26, 2020 | Jul 7, 2020 | Jun 15, 2020 | $0.61 | Quarterly |
Jan 28, 2020 | Apr 7, 2020 | Mar 16, 2020 | $0.61 | Quarterly |
Nov 19, 2019 | Jan 8, 2020 | Dec 16, 2019 | $0.61 | Quarterly |
Jul 23, 2019 | Oct 7, 2019 | Sep 16, 2019 | $0.55 | Quarterly |
May 28, 2019 | Jul 8, 2019 | Jun 17, 2019 | $0.55 | Quarterly |
Jan 29, 2019 | Apr 5, 2019 | Mar 15, 2019 | $0.55 | Quarterly |
Oct 25, 2018 | Jan 8, 2019 | Dec 17, 2018 | $0.55 | Quarterly |
Jul 24, 2018 | Oct 5, 2018 | Sep 17, 2018 | $0.48 | Quarterly |
May 22, 2018 | Jul 9, 2018 | Jun 15, 2018 | $0.48 | Quarterly |
Jan 23, 2018 | Apr 6, 2018 | Mar 15, 2018 | $0.48 | Quarterly |
Nov 28, 2017 | Jan 8, 2018 | Dec 15, 2017 | $0.48 | Quarterly |
Jul 25, 2017 | Oct 6, 2017 | Sep 15, 2017 | $0.47 | Quarterly |
May 23, 2017 | Jul 10, 2017 | Jun 15, 2017 | $0.47 | Quarterly |
Feb 28, 2017 | Apr 7, 2017 | Mar 15, 2017 | $0.47 | Quarterly |
Nov 22, 2016 | Jan 9, 2017 | Dec 15, 2016 | $0.47 | Quarterly |
Jul 26, 2016 | Oct 7, 2016 | Sep 15, 2016 | $0.46 | Quarterly |
May 24, 2016 | Jul 8, 2016 | Jun 15, 2016 | $0.46 | Quarterly |
Feb 23, 2016 | Apr 7, 2016 | Mar 15, 2016 | $0.46 | Quarterly |
Nov 24, 2015 | Jan 8, 2016 | Dec 15, 2015 | $0.46 | Quarterly |
Jul 22, 2015 | Oct 7, 2015 | Sep 15, 2015 | $0.45 | Quarterly |
May 26, 2015 | Jul 8, 2015 | Jun 15, 2015 | $0.45 | Quarterly |
Feb 24, 2015 | Apr 8, 2015 | Mar 16, 2015 | $0.45 | Quarterly |
Nov 25, 2014 | Jan 8, 2015 | Dec 15, 2014 | $0.45 | Quarterly |
Jul 23, 2014 | Oct 7, 2014 | Sep 15, 2014 | $0.44 | Quarterly |
May 27, 2014 | Jul 8, 2014 | Jun 16, 2014 | $0.44 | Quarterly |
Feb 25, 2014 | Apr 7, 2014 | Mar 17, 2014 | $0.44 | Quarterly |
Nov 26, 2013 | Jan 8, 2014 | Dec 16, 2013 | $0.44 | Quarterly |
Jul 24, 2013 | Oct 7, 2013 | Sep 16, 2013 | $0.43 | Quarterly |
May 28, 2013 | Jul 8, 2013 | Jun 17, 2013 | $0.43 | Quarterly |
Feb 26, 2013 | Apr 5, 2013 | Mar 15, 2013 | $0.43 | Quarterly |
Nov 27, 2012 | Jan 8, 2013 | Dec 17, 2012 | $0.43 | Quarterly |
Related Companies
View additional S&P 500 companies similar to Merck & Co. (MRK)
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2024 Financhle. All Rights Reserved.